Published on
January 6, 2022
- 16:00 GMT
Orbit Genomics Raises $3 Million to Launch a Lung Cancer Diagnostic Test
Orbit Genomics' prototype lung cancer test, demonstrated unparalleled accuracy for diagnosing lung cancer in a peer reviewed pilot study. BOULDER, COLORADO, UNITED STATES, January 6, 2022 /EINPresswire.com/ -- Orbit Genomics, Inc., an early-stage …
Distribution channels:
Healthcare & Pharmaceuticals Industry, Science
...
